Surveyed Oncologists Expect to Prescribe Provenge to about Half of Their Prostate Cancer Patients if the Vaccine is Approved

WALTHAM, Mass., July 28 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, if Dendreon's Provenge receives regulatory approval, surveyed oncologists expect to prescribe Provenge to ...

Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill

WASHINGTON, July 8 /PRNewswire/ -- Today almost 100 patients and oncologists, who are members of the Community Oncology Alliance (COA), will meet on Capitol Hill to rally in support of health care reform, spotlighting cancer care and the needs of cancer patients. COA will announce and discuss the ...

Call to Action: Community Oncologists Propose 'Roadmap' to Reformed Payment System for Cancer Care; Quality Cancer Care Demonstration Project Will Create System, Enhancing Quality Cancer Care While Controlling Costs

WASHINGTON, May 26 /PRNewswire/ -- The Community Oncology Alliance (COA) announced today that it has created the Quality Cancer Care Demonstration (QCCD) project, a landmark initiative to transform the payment system for cancer care. The QCCD will focus on patients covered by Medicare (appro...

Published Data Confirms First 3D Ultrasound for Breast Cancer Treatment Planning Helps Radiation Oncologists Better Define Treatment Region

International Journal of Radiation Oncology*Biology*Physics Study Finds that Resonant Medical's Clarity Breast System Provides Enhanced Image Information for Planning Partial Breast Irradiation Treatment MONTREAL, March 4 /PRNewswire/ -- Researchers report in the February 1st issue of the Int...

Surveyed Oncologists Indicate that Avastin has Advantages over Temodar/Temodal in Increasing Overall Survival of High-Grade Glioma

A Drug That Improves Survival, When Added to Temodar/Temodal, Would Earn a 65 Percent Patient Share in the U.S. and a 30 Percent Patient Share in Europe in Newly Diagnosed Glioblastoma Multiforme, According to a New Report from Decision Resources WALTHAM, Mass., March 9 /PRNewswire/ -- Deci...

Society of Gynecologic Oncologists to Host 40th Annual Meeting on Women's Cancer

CHICAGO, Jan. 9 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) will host its 40th Annual Meeting on Women's Cancer, February 5-8, 2009 at the Henry B. Gonzalez Convention Center in San Antonio, Texas. This year's meeting will feature more than 360 scientific presentations...

MedTrust Online Collaborates With Oracle and Dell to Provide Oncologists With the Next Generation Tool for Personalized Care Delivery

SCOTTSDALE, Ariz., May 29 /PRNewswire/ -- MedTrust Online, LLC, a provider of clinically-useful applications for Oncologists, is working with Oracle, the world's largest enterprise software company, and Dell, a global leader in Information Technology (IT) solutions, to bring the new discoverie...

Society of Gynecologic Oncologists 39th Annual Meeting on Women's Cancer to Include Sessions on HPV and Cervical Cancer

Eight Sessions to be Dedicated to the Prevention and Treatment of Cervical Cancer and HPV's Related Correlation to the Disease CHICAGO, March 10 /PRNewswire-USNewswire/ -- It has been almost two years since the first vaccine to prevent cervical cancer was approved for regular clinical use,...

South Florida Gynecologic Oncologists Begin Using LUMA(R) Cervical Pre-Cancer Imaging Device

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- SpectraScience, Inc. (OTC Bulletin Board: SCIE), a San Diego based medical devices company, today announced that it has placed its LUMA Cervical Imaging System to detect pre-cancers at the South Florida Gynecologic Oncology Center under the directio...

Society of Gynecologic Oncologists to Host 39th Annual Meeting on Women's Cancer

'Scientific Innovation - Pathway to Progress in Women's Cancer' Theme Spotlights Four Decades of Advances in Prevention and Treatment of Gynecologic Cancers CHICAGO, Feb. 11 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) will host its 39th Annual Meeting on Wom...

Oncologists in Medical Technology

Society of Gynecologic Oncologists Issues White Paper on HPV Vaccine's Impact on Cervical Cancer Prevention

Paper is First in a Series Based on Presentations from Cervical Cancer Prevention Forum Hosted by SGO CHICAGO, Aug. 3 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) has published the first in a series of four papers on a variety of cervical cancer i...

Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer to Include Sessions on Robotics Surgery

How is this New Surgery Technique Impacting the Treatment of Women's Cancers? CHICAGO, Jan. 29 /PRNewswire-USNewswire/ -- Robotic-assisted surgery has become one of the fastest growing technological advances in the field of Gynecologic Oncology in the past few years. This minimally-invasive s...

Surveyed Oncologists Say That the Most Promising Targeted Therapy in Adjuvant Clinical Trials is Avastin for the Treatment of Early-Stage Colorectal Cancer

Despite Widespread Use, Formulary Coverage of Targeted Cancer Therapies is Inconsistent, According to a New Report from Decision Resources WALTHAM, Mass., Oct. 14 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issu...

News Media Advisory: World's Leading Surgical Oncologists to Gather at McLaren Regional Medical Center to Present Latest Work on Breast, Gastrointestinal Cancer Treatments

FLINT, Mich., Oct. 7 /PRNewswire/ -- McLaren Health Care and its Great Lakes Cancer Institute are gathering some of the world's leading medical minds to share the latest work underway around the globe on breast and gastrointestinal cancer treatments. The October 11th symposium, hosted by McLar...

SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists

CHICAGO, March 2 /PRNewswire-USNewswire/ -- The Society of Gynecologic Oncologists (SGO) and the American College of Obstetricians and Gynecologists (ACOG) have jointly developed a breast disease fellowship training program for gynecologic oncologists. Supported by a grant of $75,000 fr...

Vermillion Receives Award From the Society of Gynecologic Oncologists

Company to Present New Data on its Ovarian Cancer Diagnostics Program at the Society of Gynecologic Oncologists' 39th Annual Meeting On Women's Cancer FREMONT, Calif., Feb. 28 /PRNewswire-FirstCall/ -- Vermillion, Inc. (Nasdaq: VRML ), a high-value molecular...

ApoCell's Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy

HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented the results of a study conducted by researchers at the University of Chicago and ApoCell at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago in early June. The study showed that ApoCell's adva...

Access Pharmaceuticals Provides Update on ProLindac Clinical Development Program

...acturing scale-up of ProLindac and advancing the Regulatory process with the SFDA. We are excited about finalizing protocols with ASK and the leading oncologists in China, and look forward to their continued progress," stated Jeffrey B. Davis, Access' President and CEO. "Additionally, we are meeting this month...

British Woman Celebrates a Year of Living Cancer-Free

...s gonna get really sick again," she said, "like I had before." But the new treatment succeeded where the others had failed, sparking hope among oncologists that TaNK cells could be the key to a new type of advanced cancer therapy. Doctors at the Royal Free injected Ms. Scott with natural killer (NK...

Keryx Biopharmaceuticals, Inc. Commences Phase 1 Study of KRX-0401 (Perifosine) in Recurrent Pediatric Solid Tumors at Memorial Sloan-Kettering Cancer Center

...ful for the external financial support which we have received, and we look forward to working with Drs. Becher and Holland, and their team of renowned oncologists on this study." STUDY DESIGN: The single-center, open-label, Phase 1 study is entitled "Study of Single Agent Perifosine for Recurrent P...

Oncologists in Medical Products

Orthopaedic Salvage System

Description:...Salvage System (OSS) from Biomet Inc. offers the most comprehensive joint reconstruction prostheses designed specifically for orthopaedic surgeons and oncologists who discover the following indications in their patients: significant bone loss, ligamentous deficiencies, bone tumors, multiple knee revision arthrop...
Company:Biomet Orthopedics, Inc

Oncologists in Biological News

Dana-Farber oncologists present at ASCO GU -- predict prostate cancer survival using Source MDx test

Orlando, Fla., February 27, 2009 Dana-Farber Cancer Institute (DFCI) and Source MDx today announced that Source MDx's whole blood RNA transcript-based Precision Profiles diagnostic test predicted survival in men with castration-resistant prostate cancer (CRPC). In a study of 62 CRPC patients, th...

Breakthrough in radiotherapy promises targeted cancer treatment

...r patients as it would leave less healthy tissue damaged and give radiation oncologists the possibility of instantly modifying the treatment dose as tumours change...e managed to produce high-quality, real-time MRI images, which could enable oncologists to target radiation far more accurately while it is being applied. Wor...

From cars to cancer: UH professor employs auto industry tools for tumor therapy

...o that attribute, we can say, with some degree of accuracy, the tumor will be of this size at this point." As a tumor changes, Dong said, radiation oncologists can reduce the radiation treatment volume. "Say the tumor shrinks by half. Then you can reduce the target volume and spare the normal tissue," he ...

Publication sets guidelines across cancer therapies: Ensuring the best in patient management

...y different cancers. Internationally recognized PET imaging specialists and oncologists contributed to and developed this new supplement. FDG PET is a noninvasi...e assessment in solid tumors did not exist. Because each patient is unique, oncologists have no way of accurately predicting which patient will benefit from a spec...

Joining forces to improve lung cancer treatment

... personalized therapies and closer collaborations between surgeons, medical oncologists and radiation oncologists will result in better outcomes for lung cancer patients and those at risk, ...

Taste, odor intervention improves cancer therapy, according to Virginia Tech, Wake Forest study

...rops to stimulate salivary secretion. Dietrich explained their study of the literature, and synopsis of it, is meant to increase the recognition by oncologists and physicians of the disturbances cancer patients experience in their ability to taste and smell. "Oncologists who understand the types and causes o...

New tumor markers determine therapy intensity

.... Andreas Kulozik) and in the department of molecular genetics at the German Cancer Research Center (Director: Professor Dr. Peter Lichter). Thus far, oncologists could estimate this risk only on the basis of histology findings, age at diagnosis, residual tumor after surgery, and existence of metastases at diagn...

Scattered light rapidly detects tumor response to chemotherapy

...vide representations of sub-cellular structure without disrupting the cells, and can be used to scan a large number of cells in a short time. "Now, oncologists typically judge if a chemotherapeutic agent is working by looking for shrinkage in the tumor using imaging techniques, such as MRI or PET, or patholog...

New technique images tumor vessel leakiness to predict breast cancer chemotherapy outcome

...the dose and predict effectiveness." In some cases, one chemotherapy drug may not be effective in treating the tumor, but this new technique allows oncologists to investigate other drugs sooner since they know the drug is reaching the tumor. Studies are currently underway to determine if mammography can predi...

UC Davis team refines cancer treatments to reduce potential nerve damage

... (SACRAMENTO, Calif.) While radiation treatments deliver precise doses of high-energy X-rays to stop cancer cells from spreading or to shrink tumors, oncologists have become increasingly concerned about inadvertent exposures during head and neck cancer treatments to nerves responsible for upper body mobility. T...

Oncologists in Biological Technology

StemCor Signs Agreement With Hospira to Market New Medical Device to Oncologists and Hematologists

MENLO PARK, Calif., Oct. 22 /PRNewswire/ -- StemCor Systems, Inc., a medical device company developing systems for Enabling Regenerative Medicine(TM), announced today that it has signed an agreement with Hospira, Inc. (NYSE: HSP ) to develop and commercialize StemCor's proprietary System for ...

Society of Gynecologic Oncologists to Host Cervical Cancer Prevention Forum

'The Future Strategies of Cervical Cancer Prevention: What Do We Need to Do Now to Prepare' Forum Facilitates Discussion on the Prevention of Cervical Cancer in the HPV Vaccine Era CHICAGO, Sept. 9 /PRNewswire/ -- The Society of Gynecologic Oncologists (SGO) is hosting a Cer...

ASCO Results: Oncologists Rank Genentech Number One

SAN MATEO, Calif., June 10 /PRNewswire/ -- When asked which company stood out at last week's ASCO conference in Chicago, oncologists cited Genentech at the top of the list, according to AlphaDetail, Inc., a leader in oncology primary market research and influence network mapping solutions to t...

Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists

TUSTIN, Calif., May 29 /PRNewswire/ -- Exiqon Diagnostics, announced today a strategic commercial partnership with MedTrust Online, an innovative, comprehensive internet based solution provider for oncologists that offers clinically useful knowledge on the latest topics in cancer treatment. Exiqo...

Thomas W. Burke, MD, Elected 40th President of the Society of Gynecologic Oncologists

CHICAGO, March 26 /PRNewswire/ -- Thomas W. Burke, MD, Executive Vice President and Physician-in-Chief at The University of Texas M.D. Anderson Cancer Center, has been elected the 40th President of the Society of Gynecologic Oncologists (SGO) at the organization's 39th Annual Meeting, held Mar...

The Breast Cancer Therapeutics Market in Australia

... such as the BreastScreen Australia program, which provides free mammography services to aid in the early detection of breast cancer, have resulted in oncologists seeing more early stage disease. This, combined with aggressive and targeted therapy has, in turn, resulted in a reduction in the number of locally-ad...

Monitoring Circulating Tumor Cells With the CellSearch(R) System Can Predict Prognosis in Metastatic Breast Cancer

...s blood. "Measuring CTCs in metastatic breast cancer patients provides oncologists with an additional tool to help us better monitor patient outcomes," said o...is associated with poor prognosis. "Veridex is committed to providing oncologists with high-value in vitro diagnostic solutions, such as the CellSearch(R) ...

Clarient to Present at Noble Financial's 5th Annual Equity Conference on Tuesday, June 9th

... ALISO VIEJO, Calif., June 3 /PRNewswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT ), a premier technology and services resource for pathologists, oncologists and the pharmaceutical industry, today announced that Ron Andrews , CEO and Vice Chairman, is scheduled to make an investor presentation at Noble F...

Laboratory Test May Predict Effectiveness of ERBITUX(R) for Individual Colorectal Cancer Patients

...sion Therapeutics, "Studies such as this move us a step closer to increasing the accuracy of the chemotherapy and biologic decision-making process for oncologists and their patients." About the Study The chemoresponse assay (ChemoFx(R)) was developed using four different immortalized carcinoma cell l...

Oral VDA CYT997 - Phase I Clinical Trial Presentation at ASCO

...will present preliminary data from its Phase I clinical trial of orally administered CYT997, at the Annual Meeting of the American Society of Clinical oncologists (ASCO), in Orlando, Florida, USA. Dr Alessandra Francesconi, one of the clinical investigators for the program, will be presenting the poster in ...